Adorx Therapeutics Limited
Research and experimental development on biotechnology · Edinburgh
ActiveUnited KingdomIncorporated 2017Private Limited Company
Financial position
Accounts to 2025-02-28 · GBP · company scope
Net assets
£4,860,345
Cash
£4,886,329
Turnover
—
Profit / loss
£211,002
Current assets
£4,967,039
Creditors < 1 year
£106,694
Equity
£4,860,345
Average employees
0
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2025-02-28GBP · company | 2024-02-28GBP · company | 2023-02-28GBP · company |
|---|---|---|---|
| Balance sheet | |||
| Net assets | £4,860,345 | £7,849,343 | £10,703,895 |
| Equity | £4,860,345 | £7,849,343 | £10,703,895 |
| Assets | |||
| Current assets | £4,967,039 | £9,215,415 | — |
| Cash at bank | £4,886,329 | £5,435,944 | — |
| Debtors | £80,710 | £3,779,471 | — |
| Liabilities | |||
| Creditors within one year | £106,694 | £1,366,072 | — |
| Net current assets | £4,860,345 | £7,849,343 | — |
| Profit & loss | |||
| Profit before tax | £89,415 | £11,971,761 | — |
| Profit / loss | £211,002 | £13,145,448 | — |
| People | |||
| Average employees | 0 | — | — |
| Source evidence | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesShow 1 satisfied / released
All Assets · created 2018-01-22 · satisfied 2018-03-19
—
Satisfied